- Sharing best practices for recruiting and integrating populations that are not well represented in oncology trials
- Lessons from Advancing Inclusive Research Site Alliance collaborations
- What strategies that pharma/biotech and vendor companies can design and support to help sites reach a more diverse patient population
- Measuring clinical trial carbon emission footprints
- Identifying emissions hotspots and decarbonization initiatives
- Aligning with key partners (e.g. CRO, Central Lab)
- Incentivizing the organization
- Understanding site processes and expectations to reduce delays in site initiation, activation, and screening for potential patients
- Championing collaborative sites for a streamlined trial
- Can we ever be appropriately equipped for adverse effects with off-site testing?
- Understand the reliance of both patients and doctors alike on online resources for trial and disease awareness.
- Learn about a new technology solution to search for Digital Opinion Leaders sharing content online about the therapeutic area
- Discover how to identify and track Digital Opinion Leaders across all social and online platforms
- Plan how to engage Digital Opinion Leaders in trial awareness
- A process conversation describing how “Setting Up, Scenarios, and Sticking the Landing” smooths out the road to an investment decision
- A free Public Service Announcement on how to use investment scenarios to improve your chance of “Yes!”
- Optimize employ effort
- Minimize waste and risk
- Appreciate significant savings
- Sustainably friendly
